Veterinary Medicines

AAGENT 100 mg/ml, soluzione iniettabile per vitelli e suinetti nel primo mese di vita

Authorised
  • Gentamicin
Download as PDF

Identifikacija zdravila

Ime zdravila:
AAGENT 100 mg/ml, soluzione iniettabile per vitelli e suinetti nel primo mese di vita
Učinkovina:
Ciljne živalske vrste:
Pot uporabe:
  • Intravenska uporaba
  • intramuskularna uporaba

Podatki o zdravilu

Učinkovina / Jakost:
  • Na voljo samo v English
    100.00
    milligram(s)
    /
    1.00
    millilitre(s)
Farmacevtska oblika:
  • Raztopina za injiciranje
Withdrawal period by route of administration:
  • Intravenous use
    • tele
      • Meat and offal
        192
        day
    • Pig (piglet)
      • Meat and offal
        146
        day
  • Intramuscular use
    • tele
      • Meat and offal
        192
        day
    • Pig (piglet)
      • Meat and offal
        146
        day
Anatomsko-terapevtsko-kemična veterinarska oznaka (ATCvet):
  • QJ01GB03
Pravni status za dobavo / izdajo zdravila:
  • Zdravilo, ki se izdaja na veterinarski recept
Status dovoljenja:
  • Valid
Authorised in:
  • Italy
Available in:
  • Italy
Opis ovojnine:

Dodatne informacije

Entitlement type:
Pravna podlaga za izdajo dovoljenja za promet z zdravilom:
Imetnik dovoljenja za promet z zdravilom:
  • Fatro S.p.A.
Marketing authorisation date:
Proizvodna mesta, odgovorna za sproščanje serij:
  • Fatro S.p.A.
Pristojni organ:
  • Ministry Of Health
Številka dovoljenja :
Ta podatek za to zdravilo ni na voljo.
Datum spremembe statusa dovoljenja:

Dokumenti

Combined File of all Documents

Ta dokument ne obstaja v tem jeziku (slovenščina). Spodaj ga najdete v drugem jeziku.
Italian (PDF)
Objavljeno na: 9/06/2022
Prenesi
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."